Patient selection criteria for an effective laparoscopic intraperitoneal ventral hernia repair in day surgery.


Journal

Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 14 01 2018
accepted: 10 12 2018
pubmed: 21 12 2018
medline: 30 1 2020
entrez: 21 12 2018
Statut: ppublish

Résumé

The laparoscopic treatment of abdominal wall defects is currently a valid alternative to the open technique, given the possibility to significantly reduce the length of hospital stay and, consequently, to allow its carrying out in a day surgery setting. The comparison between the two methods has also been the subject of a Cochrane meta-analysis performed by Sauerland et al. (Cochrane Database Syst Rev 3: CD007781, 2011), which pointed out how, in spite of many clinical trials indicating the superiority of laparoscopy in terms of invasiveness and postoperative pain control, the quality of evidence is low due to the excessive variability among the different series in terms of reported complications. Moreover, what should be the selection criteria of patients fit for laparoscopic treatment in day surgery is not yet defined. This retrospective study considered 94 patients with primary or recurrent incisional wall hernias treated with laparoscopic technique over a 7-year period of time, from 2011 to 2018. The aim was to define the selection criteria for an effective day surgery laparoscopic treatment, considering as outcome the rate of conversion to ordinary hospitalization (discharge > POD1). Discharge > POD 1 was necessary in 15 cases out of 94 (16%). Concerning this outcome, statistically significant risk factors were ASA score > I (p = 0.022), number of hernia orifices > 1 (p = 0.001), recurrent hernias (p = 0.002) and hernia diameter > 10 cm (p < 0.0001). These factors were confirmed by univariate binary logistic analysis. A stepwise model of multivariate analysis showed as determinants for adverse events ASA score > 1 (OR 5.2, 95% CI 1.1-25.6, p = 0.043) and hernias > 10 cm (OR 7.0, 95% CI 1.1-46.4, p = 0.045). This work highlighted some useful criteria for preoperative selection of patients fit for laparoscopic abdominal wall defects repair in a day surgery setting. In particular, criteria related to a favorable clinical outcome were ASA score < II and a hernia diameter < 10 cm.

Identifiants

pubmed: 30569347
doi: 10.1007/s13304-018-00616-x
pii: 10.1007/s13304-018-00616-x
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-553

Références

Hernia. 2002 Mar;6(1):21-5
pubmed: 12090576
Curr Surg. 2003 May-Jun;60(3):287-91
pubmed: 14972258
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Arch Surg. 2005 Feb;140(2):119-23
pubmed: 15723991
Surgery. 2005 Oct;138(4):708-15; discussion 715-6
pubmed: 16269300
Surg Endosc. 2006 Jan;20(1):71-5
pubmed: 16333530
Chir Ital. 2005 Nov-Dec;57(6):709-16
pubmed: 16400765
Hernia. 2006 Apr;10(2):110-9
pubmed: 16453075
Surg Endosc. 2007 Apr;21(4):555-9
pubmed: 17364151
Arch Surg. 2007 Jun;142(6):562-7
pubmed: 17576893
Hernia. 2008 Apr;12(2):177-83
pubmed: 18085347
Cir Esp. 2008 Jan;83(1):3-7
pubmed: 18208741
Surg Clin North Am. 2008 Feb;88(1):85-100, viii
pubmed: 18267163
Surg Endosc. 2008 Sep;22(9):1935-40
pubmed: 18528613
Surg Laparosc Endosc Percutan Tech. 2008 Jun;18(3):267-71
pubmed: 18574413
Surg Endosc. 2008 Oct;22(10):2244-50
pubmed: 18622552
J Laparoendosc Adv Surg Tech A. 2009 Apr;19(2):175-9
pubmed: 19216699
Am J Surg. 2009 Mar;197(3):353-9
pubmed: 19245914
Br J Surg. 2009 Aug;96(8):851-8
pubmed: 19591158
Hernia. 2010 Apr;14(2):123-9
pubmed: 20155431
Ann Plast Surg. 2010 May;64(5):696-8
pubmed: 20395790
Arch Surg. 2010 Apr;145(4):322-8; discussion 328
pubmed: 20404280
Surg Innov. 2010 Dec;17(4):285-90
pubmed: 20817641
Ann Surg. 2011 Jan;253(1):16-26
pubmed: 21135699
Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007781
pubmed: 21412910
Dan Med Bull. 2011 Dec;58(12):B4369
pubmed: 22142580
Hernia. 2015 Jun;19(3):487-92
pubmed: 24609586
Surg Laparosc Endosc. 1993 Feb;3(1):39-41
pubmed: 8258069

Auteurs

Luca Domenico Bonomo (LD)

Visceral Sarcoma Unit, Città della Salute e della Scienza di Torino, Cso Bramante 88, 10126, Turin, Italy.

Michele Giaccone (M)

Visceral Sarcoma Unit, Città della Salute e della Scienza di Torino, Cso Bramante 88, 10126, Turin, Italy.

Alice Caltagirone (A)

Visceral Sarcoma Unit, Città della Salute e della Scienza di Torino, Cso Bramante 88, 10126, Turin, Italy.

Alex Bruno Bellocchia (AB)

Visceral Sarcoma Unit, Città della Salute e della Scienza di Torino, Cso Bramante 88, 10126, Turin, Italy.

Mariateresa Grasso (M)

Visceral Sarcoma Unit, Città della Salute e della Scienza di Torino, Cso Bramante 88, 10126, Turin, Italy.

Antonella Nicotera (A)

Visceral Sarcoma Unit, Città della Salute e della Scienza di Torino, Cso Bramante 88, 10126, Turin, Italy.

Nicolò Lano (N)

Visceral Sarcoma Unit, Città della Salute e della Scienza di Torino, Cso Bramante 88, 10126, Turin, Italy.

Sergio Sandrucci (S)

Visceral Sarcoma Unit, Città della Salute e della Scienza di Torino, Cso Bramante 88, 10126, Turin, Italy. sergio.sandrucci@unito.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH